AstraZeneca in $1.15B Deal for Pearl Therapeutics

June 10 (Bloomberg) -- Bloomberg's Anna Edwards reports that AstraZeneca has agreed to a $1.15 billion deal to buy Pearl Therapeutics, a maker of therapies for respiratory disease. She speaks on Bloomberg Television's "Countdown."

Harte, Calvasina on the Impact of Bank Stress Tests
54:23 - Jeffery Harte, analyst at Sandler O'Neill, and Lori Calvasina, chief U.S. equity strategist at Credit Suisse Securities, discuss stress tests on banks and what it means for investing. They speak with Bloomberg's Alix Steel and Jonathan Ferro on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • Merkel Says EU Treaty Changes May Be Needed
  • Full Show: Surveillance (06/23)
  • Airline and Aerospace in Newfoundland